Strava Healthcare is the leading manufacturer of dihydroartemisinin piperaquine phosphate (DHA-PQP) tablets in India for domestic and international pharmaceutical markets. This artemisinin-based combination therapy (ACT) is majorly used for uncomplicated malaria treatment and delivers a simplified once-daily dosing schedule that improves patient adherence.
Why DHA-PQP?
Dihydroartemisinin delivers rapid-acting parasite that will kill while piperaquine delivers a prolonged post-treatment protective effect due to its prolonged half-life. The integration is effective against multidrug-resistant Plasmodium falciparum strains which is found across Southeast Asia and sub-Saharan Africa.
Clinical Use
- Uncomplicated Plasmodium falciparum malaria
- Recommended for areas with known chloroquine or SP resistance
- Once-daily dosing for 3 days simpler than most ACTs
Manufacturing Quality
Each batch is purely manufactured under GMP conditions and tested for assay, dissolution, content uniformity, and microbiological purity. Full batch documentation and third-party COAs are also available.
Export & Institutional Supply
We supply DHA-PQP tablets to NGOs, NMCPs, and pharma importers in malaria-endemic regions. WHO prequalification dossier support is available on request. Dihydroartemisinin piperaquine phosphate (DHA-PQP) tablets are in good demand in the countries like Sudan, South Sudan, Nigeria, Ghana, Kenya, Malawi, Zambia, Angola, eritrea, Djibouti, Somalia, Senegal, Sierra Leone, Liberia, Democratic Republic of the Congo, Indonesia, Myanmar, Thailand, Vietnam, Cambodia, Laos, China, Pakistan, Sudan, Somalia, Brazil, Peru, Colombia.
Product Specifications
| Parameter | Details |
|---|---|
| Active Ingredients | Dihydroartemisinin + Piperaquine Phosphate |
| Strengths | 20 mg / 160 mg per tablet |
| 40 mg / 320 mg per tablet | |
| 60 mg / 480 mg per tablet | |
| Dosage Form | Film-coated Tablet |
| Pack Sizes | Blister packs (3-day course) pack of 9 tablets |
| Storage | Below 30°C, protect from humidity |
| Shelf Life | 36 months |
| Manufacturer | Strava Healthcare Private Limited |
Frequently Asked Questions
Once daily for three days. Dosing is weight-band based typically one to four tablets per day again depending on the patient’s body weight. Always follow the prescribing physician’s instructions.
DHA-PQP is generally not recommended in the first trimester. Use in second and third trimesters should follow national malaria treatment guidelines and physician advice.
Yes. We supply DHA-PQP tablets to NGOs, NMCPs, and institutional buyers in low and middle-income countries. Pricing and lead times are available on inquiry.
Yes. We can support dossier preparation for WHO PQ and regulatory submissions in semi-regulated markets.